Skye Bioscience's total assets for Q were $11.94M, a decrease of -23.48% from the previous quarter. SKYE total liabilities were $14.07M for the fiscal quarter, a 1.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.